I occasionally check in on the thread. What is the question?
It should not be decided locally. Follow the IFU from the manufacturer. A particular assay on a particular analyzer will have instructions for use determined by the manufacturers testing as part of the approval process for that assay. CLIA is pretty strict about following instructions. I am not a laboratorian.
And the more contagious variants have typically replicated more easily and so you really don't need a more sensitive naat (includes pcr) because the viral load (and thus probe targets) are equal or higher sooner than Wuhan-1.
Bookmarks